James Healy - Jan 25, 2024 Form 3 Insider Report for ArriVent Biopharma, Inc. (AVBP)

Role
Director
Signature
/s/ James Kastenmayer, Attorney-in-Fact for James Healy
Stock symbol
AVBP
Transactions as of
Jan 25, 2024
Transactions value $
$0
Form type
3
Date filed
1/25/2024, 08:37 PM
Previous filing
Dec 22, 2023
Next filing
Jan 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AVBP Series B Preferred Stock Jan 25, 2024 Common Stock 1.25M Sofinnova Venture Partners XI, L.P. F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of preferred stock will automatically convert into the Issuer's common stock in accordance with the Issuer's Amended and Restated Certificate of Incorporation immediately prior to the completion of the Issuer's initial public offering.
F2 Not Applicable.
F3 The shares of preferred stock will convert into common stock immediately prior to the closing of the Issuer's initial public offering using a calculation defined in the Issuer's Amended and Restated Certificate of Incorporation, as amended, based on the initial purchase price and the conversion rate in effect at the time of conversion. The shares of preferred stock will convert on a 1-for-15.21 basis and such conversion rate is reflected in the amount of common stock underlying the security.
F4 The shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.

Remarks:

Exhibit 24.1 - Power of Attorney